University College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Sheffield Featured PhD Programmes
European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
"antimicrobial"×
10 miles

antimicrobial PhD Projects, Programs & Scholarships

We have 59 antimicrobial PhD Projects, Programs & Scholarships

  • "antimicrobial" ×
  • clear all
Order by 
Showing 1 to 10 of 59
  Systems, Structures and Change: Conceptualising and Intervening on Antimicrobial Resistance (AMR) in Low-and- Middle-Income Countries (LMICs)
  Dr J Dixon, Prof M Gorsky
Application Deadline: 4 October 2019

Funding Type

PhD Type

2019-20 Medical Research Foundation National PhD Training Programme in Antimicrobial Resistance Research PhD Studentship.
  Expressions of Interest for a PhD Opportunity in Novel Neutrophil-derived Antimicrobial Proteins (for application to the 2020 IRC GOIPG Scholarship)
  Dr EP Reeves, Dr M Murphy
Application Deadline: 20 September 2019

Funding Type

PhD Type

Supervisors. Dr. Emer Reeves, Primary supervisor; Dr. Mark Murphy, Co-supervisor. Host Institution. Royal College of Surgeons in Ireland.
  Genome mining of novel antimicrobial natural products from new bacterial strains
  Dr H Deng, Prof M Jaspars
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is rising to dangerously high levels in all parts of the world. In Europe alone, drug-resistant bacteria are estimated to cause 25,000 deaths annually and cost more than US$1.5 billion every year in healthcare expenses and productivity losses.
  Promoting Use and Non-Use: Medicines for Tuberculosis and other Bacteria in an Era of Antimicrobial Resistance
  Dr J Dixon, Prof M Gorsky
Application Deadline: 4 October 2019

Funding Type

PhD Type

2019-20 Medical Research Foundation National PhD Training Programme in Antimicrobial Resistance Research PhD Studentship.
  Understanding and combatting antimicrobial resistance plasmids
  Dr M Buckner, Dr J Blair
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is a major crisis for human medicine. Globally, untreatable bacterial infections are rapidly increasing, leaving us with limited treatment options.
  Contribution of wild birds to antimicrobial resistance in the environment and on farm (WILBR) medical / environmental science – PhD (Funded)
  Dr M Anjum, Prof W Gaze
Application Deadline: 30 September 2019

Funding Type

PhD Type

The University of Exeter’s College of Medicine and Health, in partnership with the Animal and Plant Health Agency is inviting applications for a fully-funded PhD studentship to commence in November 2019 or as soon as possible thereafter.
  New antimicrobial agents for biofilm-related infections
  Dr K Fairfull-Smith
Applications accepted all year round

Funding Type

PhD Type

The adhesion of bacteria to surfaces and their subsequent ability to aggregate into colonies called biofilms is a significant problem in healthcare systems around the world.
  Understanding Synergistic Antimicrobial Technologies using Advanced Physical and Biological Sciences Techniques
  Prof R Raval, Dr D Bennett
Application Deadline: 30 September 2019

Funding Type

PhD Type

This opportunity will close once a suitable candidate has been found.
  Cationic antimicrobial peptides as anticancer agents
  Dr R Green, Prof R A Frazier
Applications accepted all year round

Funding Type

PhD Type

Cationic peptides are widespread in nature where they play a key role in host defense within plants and animals. The mechanism by which these peptides interact with cell membranes potentially leads to these being less prone to antimicrobial resistance than conventional antibiotics.
  Intra-intestinal inactivation of residual antibiotics as a promising approach to fight against antimicrobial resistance.
  Dr M Khoder
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is a grave threat to public health causing 50000 deaths per year in the US and Europe alone. With virtually no new antibiotic classes created in the new millennia, identifying novel strategies to preserve and extend the useful life of existing antibiotics has therefore become a priority.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.